MD-401 — Medical Cannabis Therapeutics (CME)

Clinical evidence, safe prescribing, ethics, and regulatory compliance in medical cannabis therapeutics — accredited by the CLA Medical Division.

At-a-Glance

MD-401 quick facts
Item Details
Module Code MD-401
Title Medical Cannabis Therapeutics (CME)
Duration & Delivery 25 hours total
• 18h e-learning (asynchronous modules)
• 7h clinical case seminars (live virtual / in-person hybrid)
Target Audience Licensed medical practitioners — physicians, specialists, pharmacists, and allied health professionals seeking CME credits under CLA accreditation.
Certificate Awarded “CME Certificate — Medical Cannabis Therapeutics”
Validity: 2 years (renewal via updated CME credits)
Accreditation CLA Medical Division • CME credits via partner medical board

Learning Outcomes

  • Identify therapeutic indications and contraindications of medical cannabis based on current evidence.
  • Apply safe prescribing practices: dosage, titration, and administration routes.
  • Manage drug interactions (opioids, benzodiazepines, antiepileptics, etc.).
  • Recognize and report Serious Adverse Events (SAEs) under CLA pharmacovigilance protocols.
  • Integrate cannabis into patient care ethically and legally within clinical practice.

Curriculum Breakdown (25 Hours)

  • Module 1 (4h): Foundations
    Endocannabinoid system • Pharmacology of cannabinoids (THC, CBD, minor cannabinoids) • Receptor interactions, metabolism, pharmacokinetics
  • Module 2 (4h): Clinical Indications & Evidence
    Pain management • Oncology • Neurology (epilepsy, MS, Parkinson’s) • Psychiatry (PTSD, anxiety, depression) • Palliative care
  • Module 3 (4h): Contraindications & Risk Management
    Cardiovascular, psychiatric, developmental risks • Special populations (pediatrics, geriatrics, pregnancy/lactation) • SAE reporting
  • Module 4 (4h): Prescribing & Dispensing Standards
    Dosing ranges • Titration • Delivery forms (oils, capsules, vaporization, topicals) • Interactions • Prescription templates (CLA)
  • Module 5 (2h): Ethics, Law & Practice
    Dominica’s Integrated Cannabis Act • Patient confidentiality & informed consent • Cross-border medical frameworks (CARICOM & international law)
  • Module 6 (7h): Clinical Case Seminars (Live)
    Case-based discussions (oncology, chronic pain, epilepsy, mental health) • Prescribing simulations • SAE drills

Assessment

  • Multiple Choice Exam (50 Q) — 40%
  • Clinical Vignette Analysis (written) — 30%
  • Case Simulation (live/OSCE style) — 30%

Resources & Materials

Digital handbook — “Medical Cannabis Clinical Guide” (CLA edition)
Case vignette library • Prescription & SAE reporting templates

License Alignment

Mandatory for: Medical practitioners prescribing cannabis under CLA oversight.
Recommended for: Pharmacists and allied health professionals supporting patient care.

Recognized by Industry & Government

CaribCanna – The Caribbean Academy of Cannabis Sciences – is the recognized training provider accredited to deliver the mandatory Licensing Programs in Dominica.

© Copyright 2025 Caribbean Institute of Cannabis . All right reserved.

Scroll to Top